How to help countries improve resilience during a pandemic: an example of a Rapid Exchange Forum.


Journal

European journal of public health
ISSN: 1464-360X
Titre abrégé: Eur J Public Health
Pays: England
ID NLM: 9204966

Informations de publication

Date de publication:
01 Jul 2024
Historique:
medline: 1 7 2024
pubmed: 1 7 2024
entrez: 1 7 2024
Statut: ppublish

Résumé

The COVID-19 pandemic demanded quick exchanges between experts and institutions supporting governments to provide evidence-based information in response to the crisis. Initially, there was no regular cross-country forum in the field of population health. This paper describes the set-up and benefits of implementing such a forum. A group of public health practitioners from academia, national public health institutes and ministries of health decided in April 2020 to meet bi-monthly to discuss a vast array of population health topics in a structured format called a Rapid Exchange Forum (REF). An ad-hoc mailing group was established to collect responses to questions brought forward in the forum from at least five countries within 24 h. This endeavour, which evolved as network of networks was awarded an EU grant in autumn 2020 and was called PHIRI (Population Health Information Research Infrastructure). Responses from up to 31 countries were compiled and shared immediately via the European Health Information Portal. This exchange was complemented by special REFs that focused on the advantages and disadvantages of vaccination, for example. By July 2023, 54 REFs had taken place with topics going beyond COVID-19. The REF demonstrated its value for quick yet evidence-based cross-country exchange in times of crisis and was highly appreciated by countries and European Commission. It demonstrated its sustainability even after the acute crisis by expanding the topics covered and managing to continue exchange with the aim of capacity building and mutual learning, making it a true EU response and coordination mechanism.

Sections du résumé

BACKGROUND BACKGROUND
The COVID-19 pandemic demanded quick exchanges between experts and institutions supporting governments to provide evidence-based information in response to the crisis. Initially, there was no regular cross-country forum in the field of population health. This paper describes the set-up and benefits of implementing such a forum.
METHODS METHODS
A group of public health practitioners from academia, national public health institutes and ministries of health decided in April 2020 to meet bi-monthly to discuss a vast array of population health topics in a structured format called a Rapid Exchange Forum (REF). An ad-hoc mailing group was established to collect responses to questions brought forward in the forum from at least five countries within 24 h. This endeavour, which evolved as network of networks was awarded an EU grant in autumn 2020 and was called PHIRI (Population Health Information Research Infrastructure).
RESULTS RESULTS
Responses from up to 31 countries were compiled and shared immediately via the European Health Information Portal. This exchange was complemented by special REFs that focused on the advantages and disadvantages of vaccination, for example. By July 2023, 54 REFs had taken place with topics going beyond COVID-19.
CONCLUSION CONCLUSIONS
The REF demonstrated its value for quick yet evidence-based cross-country exchange in times of crisis and was highly appreciated by countries and European Commission. It demonstrated its sustainability even after the acute crisis by expanding the topics covered and managing to continue exchange with the aim of capacity building and mutual learning, making it a true EU response and coordination mechanism.

Identifiants

pubmed: 38946451
pii: 7701777
doi: 10.1093/eurpub/ckae035
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

i81-i86

Subventions

Organisme : European Commission via the HORIZON 2020 programme
ID : GA 101018317

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Public Health Association.

Auteurs

Claudia Habl (C)

International Affairs, Policy, Evaluation and Digitialisation, Gesundheit Österreich GmbH, Vienna, Austria.

Johannes Weiss (J)

International Affairs, Policy, Evaluation and Digitialisation, Gesundheit Österreich GmbH, Vienna, Austria.

Anita Gottlob (A)

International Affairs, Policy, Evaluation and Digitialisation, Gesundheit Österreich GmbH, Vienna, Austria.

Miriam Saso (M)

EU Health Information System Department, Sciensano, Brussels, Belgium.

Nienke Schutte (N)

EU Health Information System Department, Sciensano, Brussels, Belgium.

Petronille Bogaert (P)

EU Health Information System Department, Sciensano, Brussels, Belgium.

Marília Silva Paulo (MS)

CHRC, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.

Luís Velez Lapão (LV)

CHRC, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.
UNIDEMI, NOVA FCT, Universidade Nova de Lisboa, Lisbon, Portugal.
LASI Intelligente Systems Associated Laboratory, Guimarães, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH